UBS Group
ZJYL

UBS Group’s Jin Medical International ZJYL Stock Holding History

UBS Group’s Portfolio ZJYL Stock Details ZJYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77K Sell
971
-252
-21% -$579 ﹤0.01% 9479
2026
Q1 		$2.47K Buy
1,223
+999
+446% +$2.96K ﹤0.01% 9267
2025
Q4 		$987 Sell
224
-1,860
-89% -$11K ﹤0.01% 9740
2025
Q3 		$23.6K Sell
2,084
-2,608
-56% -$33.3K ﹤0.01% 8047
2025
Q2 		$61K Sell
4,692
-3,835
-45% -$58.4K ﹤0.01% 7610
2025
Q1 		$127K Sell
8,527
-1,024
-11% -$17K ﹤0.01% 6862
2024
Q4 		$149K Buy
9,551
+9,446
+8,996% +$296K ﹤0.01% 6632
2024
Q3 		$5.64K Sell
105
-3,551
-97% -$214K ﹤0.01% 8039
2024
Q2 		$190K Buy
3,656
+3,644
+30,367% +$230K ﹤0.01% 5689
2024
Q1 		$945 Sell
12
-536
-98% -$78.4K ﹤0.01% 8297
2023
Q4 		$136K Buy
+548
New +$18.6K ﹤0.01% 6010
2023
Q3 		– Sell
-746
Closed -$8.51K – 10046
2023
Q2 		$8.51K Buy
+746
New +$5.67K ﹤0.01% 7234

Other funds holding ZJYL

CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

UBS Group's ZJYL Position: Q2 2026 in Review

UBS Group reduced its Jin Medical International (ZJYL) stake by 21% in Q2 2026, selling an estimated $579 and leaving 971 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #9479.

UBS Group first reported a position in ZJYL in Q2 2023 and has held it in 12 quarters since. The position peaked at $190K in Q2 2024. 3 funds tracked by Wall St. Rank hold ZJYL as of Q2 2026.

  • UBS Group held 971 shares of Jin Medical International worth $1.77K as of Q2 2026.
  • UBS Group sold 252 Jin Medical International shares in Q2 2026, an estimated $579.
  • Jin Medical International made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9479 holding.
  • UBS Group first reported a position in Jin Medical International in Q2 2023 and has held it in 12 quarters since.
  • UBS Group's Jin Medical International position peaked at $190K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Jin Medical International as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.